71 results
Page 3 of 4
8-K
EX-99.1
d6svch
4 Mar 20
Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2019 Financial Results
4:17pm
8-K
EX-99.1
i3spa4qo7y6u3n9a 3k
10 Jan 20
Regulation FD Disclosure
5:16pm
8-K
EX-99.1
3mcvnsih4 y5
6 Jan 20
Soleno Therapeutics Completes Target Enrollment in Ongoing DESTINY PWS Phase III Trial of DCCR in Prader Willi Syndrome
5:01pm
8-K
EX-99.1
fi8qoz4g
13 Nov 19
Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2019 Financial Results
6:10am
424B5
dzcbfgbu10gag0r v4f2
25 Oct 19
Prospectus supplement for primary offering
12:00am
424B5
77tsc02q1hdxcfk8s
22 Oct 19
Prospectus supplement for primary offering
4:24pm
8-K
EX-99.1
p5n x9uk46f
7 Aug 19
Soleno Therapeutics Provides Corporate Update and Reports Second Quarter 2019
4:06pm
S-3
qxozq1l8ug lu
11 Jun 19
Shelf registration
5:05pm
8-K
EX-99.1
guywls54 6jixx6whzce
13 May 19
Soleno Therapeutics Provides Corporate Update and Reports First Quarter 2019 Financial Results
8:31am
424B3
wpdeb09m3j
12 Apr 19
Prospectus supplement
4:41pm
8-K
EX-99.1
qxqmis2oq
18 Mar 19
Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2018 Financial Results
4:37pm
8-K
EX-99.1
c8wrl327wb un1ll
15 Mar 19
Other Events
9:56pm
8-K
EX-99.1
3bzcorc 54
19 Dec 18
Soleno Therapeutics Announces $16.5 Million Private Placement
4:02pm
8-K
EX-99.1
d2yqx
15 Nov 18
Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2018
4:02pm
8-K
EX-99.1
hgjqs39s 79gw8jy
14 Aug 18
Soleno Therapeutics Provides Corporate Update and Reports Second Quarter 2018 Financial Results
4:22pm
8-K
EX-99.1
on51f2r0wp
16 May 18
Soleno Therapeutics Provides Corporate Update and Reports First Quarter 2018 Financial Results
6:08am
8-K
EX-99.1
s6dhn6vhxa fvrmolh
14 May 18
Soleno Therapeutics Announces Initiation of Phase III Clinical Trial of DCCR
4:09pm